Clene Reports First Quarter 2024 Financial Results and Recent Operating Highlights
GlobeNewswire
· Data from long-term extension of Phase 2 VISIONARY-MS clinical trial of CNM-Au8^® demonstrated significant evidence of repair..
· Data from long-term extension of Phase 2 VISIONARY-MS clinical trial of CNM-Au8^® demonstrated significant evidence of repair..
CAMBRIDGE, Mass., April 22, 2024 (GLOBE NEWSWIRE) -- Anthos Therapeutics, Inc. (Anthos), is a clinical-stage company developing..
Panel of renowned cardiologists, all globally recognized experts in heart failure, will discuss the unmet medical need in pulmonary..